Please login to the form below

Not currently logged in
Email:
Password:

Off label use

This page shows the latest Off label use news and features for those working in and with pharma, biotech and healthcare.

Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD

Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD

aflibercept) squaring off against Novartis’ older drug Lucentis (ranibizumab), the first VEGF inhibitor for wet AMD to reach the market. ... Beovu represents Novartis’ attempt to defend its wet AMD franchise as Lucentis starts to decline, squeezed by

Latest news

More from news
Approximately 1 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Healthcare systems

  • The gold standard of scientific evidence The gold standard of scientific evidence

    More than one in five prescriptions in the United States are for an off-label use; providing additional evidence to better understand treatment efficacy and safety is crucial. ... A path forward. Real-world evidence is already in use around the world.

  • Does safety sell medicines? Does safety sell medicines?

    New legislation in Europe introduced in 2012 has also led companies to expand what they collect from just side effects to reports of occupational exposure, off-label use and medication errors. ... Through the collection and review of adverse event

  • Pharma deals during February 2013 Pharma deals during February 2013

    Merck &Co has also returned to the biosimilar race following its exit from the Enbrel development programme after Amgen settled an off-label use case for Aranesp in December 2012. This ... Pharma will contribute 300 compounds and the remaining 200 will

  • Changes to pharmacovigilance legislation in Europe Changes to pharmacovigilance legislation in Europe

    of the marketing authorisation (off-label use), as well as the misuse and abuse of the medicinal product. . ... More generally, the competent authority may lay down 'any other conditions or restrictions with regard to the safe and effective use of the

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • "Legal highs" ruling leaves illegal labs laughing

    This could explain the popularity of Bake Off and the reason so many Brits seem addicted to cake.  . ... There is a huge amount of off-label use of licensed medicines by medically qualified prescribers.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

talent and leadership
Leadership and talent
Looking at the key objectives of running leadership programmes...
Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....

Infographics